The present invention relates to mono- and combination therapies for melanoma, and in particular, metastatic melanoma. Drugs for use in such therapies in include RO 31-8220, bafetinib, and cardiac glycosides.
申请公布号
US2014080772(A1)
申请公布日期
2014.03.20
申请号
US201314019258
申请日期
2013.09.05
申请人
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
